Press Room

Tools and Resources for Media Professionals.

Multimedia Assets

Need a FULL press kit?

Download here.

Latest Press Release

 

Ebb Therapeutics Wins Silver at the Prestigious MDEA Awards

One of only 30 winners selected from across the globe

 

PITTSBURGH, June 26, 2018

Earlier this month, medtech start-up Ebb Therapeutics was recognized with a Silver Medal at the Medical Design Excellence Awards (MDEA). The company was the only manufacturer honored in the sleep medicine space.

MDEA, the premier awards program for the industry, recognizes significant achievements in medical product design and engineering that improve both the quality of healthcare delivery and its accessibility. Specific criteria include design and engineering innovation, user-friendly functionality and differentiated benefits for patients.

Worldwide entries are accepted, across twelve product categories and are judged by a panel of impartial jurors – clinicians, engineers and designers.
All products must have garnered FDA clearance.

Ebb Therapeutics’ winning entry, Ebb Insomnia Therapy, was successfully designed to help the millions in the U.S. who suffer with insomnia. The patented, first-of-its kind, treatment works by precisely and consistently cooling the forehead, soothing a patient’s mind and body, and allowing her/him to more quickly enter a deeper, more restorative sleep.

Don Spence, President & CEO, Ebb Therapeutics, said of the win: “The
MDEA award is the most prominent and prestigious award in the medical device industry. It’s an honor just to be recognized, but to win among this impressive competitive field, is all the sweeter. I’m especially proud of two of my colleagues and fellow executive team members, Dr. Eric Nofzinger (Founder and Chief Medical Officer) and Jeff Schirm (VP, Engineering). Eric is a world-renowned, clinical sleep specialist who discovered this effective, safe and more natural way to help millions of sufferers. Jeff and his team turned Eric’s vision into a reality, by engineering the product with uncompromising attention to detail for both efficacy and safety.

About Ebb Therapeutics

Headquartered in Pittsburgh, the privately held company was
founded in 2008 after the company’s founder, Eric Nofzinger, M.D., performed pioneering brain imaging studies on insomnia patients at the University of Pittsburgh. His research resulted in the development of Ebb Insomnia Therapy, a clinically safe, medical grade device, with none of the side effects found in traditional treatments. Ebb Therapeutics was funded in part by a grant from the National Institutes of Health, as well as by private equity and venture capital firms, KKR, Arboretum Ventures, Versant Ventures and Partner Ventures.

To learn more, visit https://ebbsleep.com

 

 

Or contact:

Elise Wilfinger

Chief Marketing Officer

203-247-7420

Ebb Therapeutics in the News

Cerêve Raises $38 Million to Fuel Launch of Insomnia Device in New Financing Led by KKR

Investment Will Fund Launch of FDA-cleared Device to Safely Treat Insomnia

OAKMONT, Pa.–(BUSINESS WIRE)–Jan. 5, 2017– Cerêve Inc., a privately-held health care company preparing to launch its FDA-cleared insomnia device, announced today the closing of a $38 million Series B round of financing led by KKR, a leading global investment firm. Also participating in the financing are existing shareholders Versant Ventures, Arboretum Ventures, and Partner Ventures.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170105005480/en/

Fifty-five million Americans have insomnia, not only experiencing problems getting to sleep but also serious impairment in their daytime activities. Currently, sleeping pills are the most common medical treatment for insomnia. According to the National Center for Health Statistics…


FDA Clears Sleep Device for Insomnia – System cools hyperactive frontal cortex

The FDA has granted commercial clearance for the Cerêve Sleep System, a prescription device that reduces latency to stage-1 and stage-2 sleep for people with insomnia.

Functional brain-imaging studies have shown that the frontal cortex, or executive brain, remains active in people with insomnia during sleep, preventing them from getting deeper, more-restorative sleep. The Cerêve Sleep System consists of a software-controlled bedside device that cools and pumps fluid to a forehead pad that is worn through the night. The pad cools the forehead within a clinically proven therapeutic range to reduce hyperactivity in the frontal cortex…


Ebb sleep in Pittsburgh Business TimesPitt spinoff on insomnia: Cooler heads do prevail

Studies at the University of Pittsburgh found that the brains of patients with insomnia were overactive. Pitt had a patent for a technique to reduce brain metabolic activity using cooling, and Dr. Eric Nofzinger saw the potential.

The burgeoning business of sleep is awakening.

Nationally, the global sleep services market is expected to reach $8.4 billion by the end of 2021, according to Persistence Market Research. And as more people are seeking new ways to bolster the quality of their shut-eye, local companies are developing products to address everything from insomnia and sleep apnea to keeping special needs kids from getting injured at night. Here are their stories…


Need a Helping Hand?

 

We’re delighted to offer our expertise in any sleep related project.
We work tirelessly every day, to help people sleep a little easier every night.

Press Contact

Elaine Lesnak

Director of Marketing Communications

412-517-6731

elesnak@ebbsleep.com

Connect with Ebb

Request a Phone Call

Have an Ebb Customer Care Coordinator contact you to discuss your next steps in getting the sleep you deserve.

* indicates required

We take your privacy extremely seriously, and we never sell lists or email addresses.View our privacy policy.